Effects of rosiglitazone and oleic acid on UCP-3 expression in L6 myotubes

Diabetes Obes Metab. 2003 Mar;5(2):136-8. doi: 10.1046/j.1463-1326.2003.00255.x.

Abstract

Aims: The regulation of uncoupling protein-3 (UCP-3) expression in muscle remains unclear, specifically in relation to dietary and drug treatments. The present study evaluated the effects of oleic acid and rosiglitazone on UCP-3 mRNA expression in differentiated L6 myotubes.

Methods: L6 myocytes were cultured and differentiated prior to exposure to rosiglitazone 10 micro mol/l, oleic acid 100 micro mol/l, or the combination, for 24 h, prior to semiquantitative evaluation of UCP-3 mRNA relative to GAPDH mRNA by RT-PCR.

Results: Exposure to oleic acid produced a significant increase in UCP-3 mRNA (0.012 +/- 0.007 vs. 0.0011 +/- 0.0006 for untreated cells, relative to GAPDH mRNA, p < 0.001). Rosiglitazone alone had no effect on UCP-3 expression and nor did the glitazone affect oleic-acid-induced upregulation of UCP-3.

Conclusions: In L6 myotubes, 24-h exposure to oleic acid produced a 10-fold increase in UCP-3 mRNA expression, but rosiglitazone had no effect. Oleic-acid-induced upregulation of UCP-3 was not affected (positively or negatively) by glitazone exposure.

MeSH terms

  • Animals
  • Carrier Proteins / metabolism*
  • Cells, Cultured
  • Drug Combinations
  • Hypoglycemic Agents / pharmacology*
  • Ion Channels
  • Mitochondrial Proteins
  • Muscle Fibers, Skeletal / metabolism*
  • Oleic Acid / pharmacology*
  • RNA, Messenger / metabolism
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rosiglitazone
  • Thiazoles / pharmacology*
  • Thiazolidinediones*
  • Uncoupling Protein 3

Substances

  • Carrier Proteins
  • Drug Combinations
  • Hypoglycemic Agents
  • Ion Channels
  • Mitochondrial Proteins
  • RNA, Messenger
  • Thiazoles
  • Thiazolidinediones
  • Ucp3 protein, rat
  • Uncoupling Protein 3
  • Rosiglitazone
  • Oleic Acid